CAR T-Cell therapy sends multiple myeloma into lasting remission – EurekAlert (press release)
FierceBiotech |
CAR T-Cell therapy sends multiple myeloma into lasting remission
EurekAlert (press release) "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission," said ASCO Expert Michael S. Sabel, MD, FACS. "It's rare to see such high response rates, especially for a hard-to-treat cancer … ASCO dark horse Nanjing Legend Biotech shines with promising CAR–T data Chinese cell therapy effective in small multiple myeloma trial bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter … |
